您现在的位置: 首页> 研究主题> CYP1A1

CYP1A1

CYP1A1的相关文献在1996年到2022年内共计992篇,主要集中在肿瘤学、药学、基础医学 等领域,其中期刊论文113篇、会议论文2篇、专利文献877篇;相关期刊88种,包括中国生育健康杂志、基础医学与临床、中国老年学杂志等; 相关会议2种,包括第五届全国中医药免疫学术研讨会暨环境·免疫与肿瘤防治综合交叉会议、2007全国环境卫生学术研讨会等;CYP1A1的相关文献由2152位作者贡献,包括蔡剑平、胡国新、戴大鹏等。

CYP1A1—发文量

期刊论文>

论文:113 占比:11.39%

会议论文>

论文:2 占比:0.20%

专利文献>

论文:877 占比:88.41%

总计:992篇

CYP1A1—发文趋势图

CYP1A1

-研究学者

  • 蔡剑平
  • 胡国新
  • 戴大鹏
  • 耿培武
  • 蔡杰
  • 杨丽萍
  • 许嘉森
  • 徐仁爱
  • 胡昌明
  • 赵薇薇
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

作者

    • Qian-lin Gu; Peng Jiang; Hui-fen Ruan; Hao Tang; Yang-bing Liang; Zhong-fu Ma; Hong Zhan
    • 摘要: BACKGROUND:We aimed to investigate the gene expression of myocardial ischemia/reperfusion injury(MIRI)in patients with acute ST-elevation myocardial infarction(STEMI)using stress and toxicity pathway gene chip technology and try to determine the underlying mechanism.METHODS:The mononuclear cells were separated by ficoll centrifugation,and plasma total antioxidant capacity(T-AOC)was determined by the ferric reducing ability of plasma(FRAP)assay.The expression of toxic oxidative stress genes was determined and verified by oligo gene chip and quantitative real-time polymerase chain reaction(qRT-PCR).Additionally,gene ontology(GO)enrichment analysis was performed on DAVID website to analyze the potential mechanism further.RESULTS:The total numbers of white blood cells(WBC)and neutrophils(N)in the peripheral blood of STEMI patients(the AMI group)were significantly higher than those in the control group(WBC:11.67±4.85×10^(9)/L vs.6.41±0.72×10^(9)/L,P<0.05;N:9.27±4.75×10^(9)/L vs.3.89±0.81×10^(9)/L,P<0.05),and WBCs were significantly associated with creatine kinase-myocardial band(CK-MB)on the first day(Y=8.945+0.018X,P<0.05).In addition,the T-AOC was significantly lower in the AMI group comparing to the control group(12.80±1.79 U/mL vs.20.48±2.55 U/mL,P<0.05).According to the gene analysis,eight up-regulated differentially expressed genes(DEGs)included GADD45A,PRDX2,HSPD1,DNAJB1,DNAJB2,RAD50,TNFSF6,and TRADD.Four down-regulated DEGs contained CCNG1,CAT,CYP1A1,and ATM.TNFSF6 and CYP1A1 were detected by polymerase chain reaction(PCR)to verify the expression at different time points,and the results showed that TNFSF6 was up-regulated and CYP1A1 was down-regulated as the total expression.GO and kyoto encyclopedia of genes and genomes(KEGG)enrichment analysis suggested that the oxidative stress genes mediate MIRI via various ways such as unfolded protein response(UPR)and apoptosis.CONCLUSIONS:WBCs,especially neutrophils,were the critical cells that mediating reperfusion injury.MIRI was regulated by various genes,including oxidative metabolic stress,heat shock,DNA damage and repair,and apoptosis-related genes.The underlying pathway may be associated with UPR and apoptosis,which may be the novel therapeutic target.
    • 李玲玲; 宋玉芳; 史奕
    • 摘要: 以赤子爱胜蚓(Eiseniafetida)为供试动物,通过微粒体提取、孵育和HPLC测定等系列条件的摸索,建立了测定其微粒体7-乙氧基-3-异吩(噁)唑酮-脱乙基酶(EROD)活性的高效液相色谱(HPLC)法.结果表明,以赤子爱胜蚓整体为材料,采用差速离心法获取微粒体进行体外孵育,反应液采用C18反相柱分离,在激发波长530 nm,发射波长582 nm条件下能够成功测定其EROD活性.组间和组内回收率在93%?118%之间,变异系数均小于15%,方法稳定.在氰戊菊酯暴露验证试验中发现氰戊菊酯暴露7d后,赤子爱胜蚓EROD活性被显著诱导,且呈现显著的量效关系,表明蚯蚓EROD活性可以作为生物标志物指示土壤拟除虫菊酯暴露的风险状况.
    • 李玲玲; 宋玉芳; 史奕
    • 摘要: 以赤子爱胜蚓(Eisenia fetida)为供试动物,通过微粒体提取、孵育和HPLC测定等系列条件的摸索,建立了测定其微粒体7-乙氧基-3-异吩(噁)唑酮-脱乙基酶(EROD)活性的高效液相色谱(HPLC)法.结果表明,以赤子爱胜蚓整体为材料,采用差速离心法获取微粒体进行体外孵育,反应液采用C18反相柱分离,在激发波长530 nm,发射波长582 nm条件下能够成功测定其EROD活性.组间和组内回收率在93%~118%之间,变异系数均小于15%,方法稳定.在氰戊菊酯暴露验证试验中发现氰戊菊酯暴露7 d后,赤子爱胜蚓EROD活性被显著诱导,且呈现显著的量效关系,表明蚯蚓EROD活性可以作为生物标志物指示土壤拟除虫菊酯暴露的风险状况.
    • 秦子飞; 王培乐; 邢晗; 韩立; 卞华; 杨晶; 张晓坚
    • 摘要: 目的 考察补骨脂富含的异戊烯基成分对CYP1A1活性的影响,并采用分子对接技术进行验证.方法 以7-乙氧基试卤灵为CYP1A1的探针底物,采用超高效液相串联三重四级杆质谱(UHPLC-TQD-MS)对代谢产物试卤灵的质谱条件进行优化;应用CYP1A1体外孵育体系,评价补骨脂富含的补骨脂二氢黄酮、补骨脂定、异补骨脂查尔酮、异补骨脂二氢黄酮和补骨脂二氢黄酮甲醚在不同浓度(1、10、100 μmol·L-1)对CYP1A1活性的影响;采用不同的抑制动力学模型计算相关的抑制常数(Ki);应用Autodock 4.2软件,将活性成分与CYP1A1进行分子对接.结果 初筛结果显示,补骨脂二氢黄酮、补骨脂定、异补骨脂查尔酮、异补骨脂二氢黄酮、补骨脂二氢黄酮甲醚对CYP1A1均表现出抑制活性,IC50 值分别为0.28、0.49、0.36、2.24、4.07 μmol·L-1;根据最小赤池信息量准则(AIC)和施瓦茨信息准则值(SC)即为最佳模型的原则,补骨脂二氢黄酮和异补骨脂查尔酮对CYP1A1的抑制为竞争性抑制,Ki常数分别为0.12、0.23 μmol·L-1;补骨脂定对CYP1A1表现出非竞争性抑制,抑制常数Ki为0.59 μmol·L-1;分子对接结果显示,补骨脂二氢黄酮和异补骨脂查尔酮与CYP1A1蛋白之间均能产生氢键、π-π键以及疏水作用,结合自由能分别为-10.145、-8.286 kcal·mol-1(1 kcal=4.2 kJ),这可能是它们与CYP1A1亲和力较强进而产生强抑制活性的原因.结论 补骨脂富含的异戊烯基成分是CYP1A1强抑制剂(IC50<5 μmol·L-1);异戊烯基成分C环1位和2位脱水开环会增加对CYP1A1的抑制活性;A环C-6位异戊烯基取代的化合物比C-8位取代的化合物表现出更强的CYP1A1抑制活性;A环7-OH甲基化会减弱CYP1A1的抑制活性;分子对接结果也证实了补骨脂二氢黄酮和异补骨脂查尔酮与CYP1A1有较强的亲和力.
    • 蔡恒; 李智文; 滕佩宏; 贾童童; 王越; 张永镇; 于向民; 王东
    • 摘要: 目的 探讨CYP1A1在孕期暴露香烟烟雾所致宫内发育迟缓( IUGR)胎鼠胎盘组织中的表达及其意义. 方法 在自制熏烟箱中制备IUGR模型,比较模型组和正常对照组胎盘中的药物代谢酶CYP1A1及细胞凋亡相关蛋白的表达量差异. 结果 IUGR模型组胎鼠的平均体重、身长、胎盘重量均明显低于对照组(P均<0.001).免疫组织化学结果显示,与对照组相比,模型组胎盘中CYP1A1表达量升高,Bcl2蛋白在胎盘中的表达降低(P<0.001),BAX蛋白表达增高(P<0.001). 结论 孕期吸烟可致金黄地鼠胎盘药物代谢酶表达升高,提示香烟烟雾中有害物质可以通过母体到达胎盘,引起胎盘细胞的死亡,影响胎盘的发育,最终导致IUGR.
    • 张毅; 闫旭; 范丽; 刘莹; 程晓莉
    • 摘要: 目的:探讨谷胱苷肽硫转移酶M1(GSTM1)和CYP1 A1 Exon7基因多态性与宫颈癌发生发展的关系.方法:选取2013年5月至2015年5月我院收治的宫颈癌患者184例为宫颈癌组,203例进行体检的健康人群为参照组.用限制性片段长度多态性-聚合酶链反应(RFLP-PCR)检测所有受试者GSTM1和CYP1A1 Ex-on7基因型;记录无进展生存期(PFS),并随访观察生存和死亡情况.结果:GSTM1分为野生型(wt)和突变缺失型(null),CYP1A1 Exon7野生型为Ⅱe/Ⅱe,突变型包括突变纯合型(VaL/Val)、突变杂合型(Ⅱe/Val).宫颈癌组携带GSTM1突变型基因型比例与参照组间比较,差异无统计学意义(P>0.05);宫颈癌组携带CYP1 A1 Exon7突变型基因型比例显著高于参照组(P<0.05),且携带突变型基因型个体患宫颈癌的风险是携带野生型基因型个体的2.333倍.GSTM1、CYP1A1 Exon7基因型与宫颈癌患者年龄、病理分期、肿瘤分化程度、肿瘤直径及淋巴结转移均无关(P>0.05),与患者病理类型有关(P<0.05).GSTM1、CYP1A1 Exon7突变型宫颈癌患者PFS中位数与野生型患者比较,差异均无统计学意义(P>0.05).GSTM1、CYP1 A1 Exon7突变型宫颈癌患者基因型与宫颈癌患者预后无关(P>0.05).结论:GSTM1及CYP1A1 Exon7基因多态性是宫颈癌发生发展的危险因素,尤其是CYP1 A1 Exon7突变型,为预防宫颈癌提供依据.
    • 余鹏; 杨雨阳; 谢德高; 高漓; 滕若冰
    • 摘要: 目的 探讨CYP1A1基因rs4646903位点多态性与特发性男性不育的关系.方法 采用Cochrane系统评价方法,检索电子数据库PUBMED、MEDLINE、EMBASE及CNKI,所有数据库检索时间限定为自建库以来至2018年8月31日,并手工检索相关参考文献,对所纳入的病例对照研究采用Stata 12.0统计软件进行分析.结果 检索到文献56篇,最终纳入8项病例对照研究,包括病例组1 640例不育男性和对照组1 794例正常生育男性.综合分析,在等位基因模型(OR=1.39,95%CI:1.05;1.84)、纯合子模型(OR=2.17,95%CI:1.24;3.79)、显性模型(OR=1.44,95%CI:1.02;2.03)和隐形模型(OR=1.83,95%CI:1.15;2.89)中观察到CYP1A1基因rs4646903位点多态性与特发性男性不育显著相关,而与野生纯合型TT比较,杂合性CT(OR=1.32,95%CI:0.97;1.79)与特发性男性不育无相关性.然而,所有的比较模型中,在进一步的亚组分析中未明确与特发性男性不育的易感性关系.结论 CYP1A1基因rs4646903位点基因多态性可能是特发性男性不育发生的影响因素之一.
    • 梁法清; 张辉; 杜正贵; 周毅; 万航宇; 吕青
    • 摘要: Objective To discuss the distribution of single nucleotide polymorphism (SNPs) of the gene of cytochrome P450 (CYP) P1A1 (rs4646903) and CYP1B1 (rs1056836) on breast cancer patients and its relation between clinical pathology.Methods A case-control study were performed to analyze 337 breast cancer patients and 469 healthy individuals taking physical examination in West China Hospital of Sichuan University from September 2012 to February 2016.The direct sequencing method was used to analyze the distribution of SNPs in the gene of CYP1A1 (rs4646903) and CYP1B1 (rs1056836),and the disparity of clinical pathological characteristics in patients with different genotype among the breast cancer population were detected.Results There was no statistic difference of the distribution of CYP1A1 (rs4646903) in genotype between the two groups (x2=0.409,P>0.05).There was a remarkable difference of the distribution of CYP1 B 1 (rs1056836) in genotype between the two groups (x2=0.009,P<0.01).In 337 cases of breast cancer patients,the distribution in the polymorphism of CYP1A1 gene (rs4646903) was not associated with the clinical pathological characteristics of the tumor.The single nucleotide polymorphism of the gene of CYP1B1 (rs1056836) had significant correlation with the metastasis of lymph node and the TNM stage(P<0.05).The homozygous mutant genotype was associated with higher negative rate of lymph node transformation and lower TNM stage.Conclusions The single nucleotide polymorphism of the gene of CYP1B1 (rs1056836) is associated with the risk of developing breast cancer.The homozygous mutant genotype in the breast cancer patients,have lower metastatic rate of axillary lymph node and TNM stage.%目的 探讨细胞色素氧化酶P450 (CYP) 1A1 (rs4646903)和CYP1B1(rs1056836)基因单核苷酸多态性(SNPs)在乳腺癌患者中的分布情况及与临床病理的关系.方法 对四川大学华西医院2012年9月至2016年2月期间收治的337例乳腺癌患者以及同期469名健康体检者进行病例对照研究,采用直接测序法分析乳腺癌患者CYP1A1(rs4646903)和CYP 1B1 (rs 1056836) SNPs的分布情况,进一步分析不同基因型患者的临床病理特征差异.结果 乳腺癌患者及健康体检者在CYP1A1(rs4646903)基因SNPs的分布上差异无统计学意义(x2=0.409,P>0.05),CYP 1B1 (rs 1056836) SNPs分布差异有统计学意义(x2=0.009,P<0.01).在337例乳腺癌病例中,CYP 1A1 (rs4646903)基因SNPs分布与肿瘤的临床病理特征无明显关系,CYP1B1 (rs1056836)基因SNPs分布与淋巴结转移状态以及TNM分期有明显相关性(P<0.05),纯合突变基因型(GG)淋巴结阴性率较高,TNM分期也较低.结论 CYP1B1 (rs1056836)基因SNPs与乳腺癌的发病风险相关,在乳腺癌患者中,纯合突变患者腋窝淋巴结转移率较低,TNM分期也较低.
    • 张利红; 石静; 郝文庆; 田竹芳; 祭美菊; 侯鹏; 李恒
    • 摘要: 目的 研究甲状腺癌中药物代谢基因CYP1A1、CYP1B1启动子区异常甲基化及其与临床病理特征之间的关系.方法 取201例甲状腺癌及23例正常甲状腺石蜡包埋组织基因组DNA,采用甲基化特异性PCR(MSP)检测上述基因启动子区甲基化状态,对比甲状腺乳头状癌(PTC)及正常对照中CYP1A1、CYP1B1基因甲基化的发生率.在体外实验中利用甲基化转移酶抑制剂5-氮-2′-脱氧胞苷(5-Aza-dC)处理5种甲状腺癌细胞系,用实时定量PCR(RT-PCR)方法检测5-Aza-dC处理前后CYP1A1、CYP1B1基因的表达变化.用logistic回归方法分析CYP1A1、CYP1B1基因的异常甲基化与临床特点之间的相关性.结果 在各种病理类型的甲状腺癌中均存在CYP1A1、CYP1B1基因甲基化的情况;在PTC中CYP1A1基因启动子区甲基化水平高于对照组,CYP1B1基因启动子区甲基化水平低于对照组;CYP1A1基因在PTC中的表达低于对照组(P<0.01),CYP1B1基因在PTC中的表达高于对照组(P<0.01);利用5-Aza-dC处理甲状腺癌细胞系后可使CYP1A1基因的表达水平在K1及C643细胞系中较对照分别升高6.92及8.30倍;CYP1B1基因在K1细胞中表达较对照升高7.62倍;CYP1B1基因启动子区甲基化与淋巴结转移呈负相关.结论 在PTC中基因启动子区甲基化调控CYP1A1及CYP1B1基因的表达,CYP1B1启动子区异常甲基化与PTC的淋巴结转移有关.%Objective To investigate the promoter methylation of drug metabolism genes CYP1A1 and CYP1B1 in thyroid cancer and its relationship with clinical pathological characteristics. Method 201 cases of thyroid cancer and 23 cases of normal thyroid tissues were involved. Methylation-specific PCR ( MSP ) was performed to analyze promoter methylation of CYP1A1 and CYP1B1 genes in the above tissues to detect the frequency of methylation positive, compare the promoter methylation level of CYP1A1 and CYP1B1 genes in papillary thyroid carcinomas ( PTC) and the controls. Five thyroid cancer cell lines were treated with methyltransferase inhibitor 5-Aza-dC for 5 days, and real time PCR ( RT-PCR) was performed to evaluate the mRNA expression of CYP1A1 and CYP1B1 genes. Logistic regression was used to analyze the correlation between the aberrant methylation and the clinical features. Results Aberrant methylation status in promoter region of CYP1A1 and CYP1B1 genes were detected in all kinds of thyroid cancers. Compared with control tissues, the methylation in promoter regions of CYP1A1 in PTCs was significantly higher, while that in promoter regions of CYP1B1 was lower (P<0.05). In vitro, 5-Aza-dC treatment significantly increased the CYP1A1 gene mRNA expression for 6. 92 and 8. 30 times in K1 and C643 cell lines respectively and restored CYP1B1 gene mRNA expression for 7.62 times in K1 cell line. Compared with the controls, PTCs with methylation in promoter regions of CYP1B1 had decreased lymphatic metastasis rate. Conclusion The methylation in promoter regions of CYP1A1 and CYP1B1 gene may regulate their mRNA expressions. Aberrant methylation of the promoter region of CYP1B1 is associated with lymph node metastasis in PTC.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号